Microtubule Regulation in Cystic Fibrosis Pathophysiology

Microtubule Regulation in Cystic Fibrosis Pathophysiology

Bibliographic Details
Main Author:	Rymut, Sharon Marie
Language:	English
Published:	Case Western Reserve University School of Graduate Studies / OhioLINK 2015
Subjects:	Pharmacology
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=case1432730616

Similar Items

Clinical pharmacokinetics of antibiotics in cystic fibrosis
by: Al-Mehsen, Fahad A.
Published: (1989)

Animal Models in the Pathophysiology of Cystic Fibrosis
by: Anna Semaniakou, et al.
Published: (2019-01-01)

CFTR and Ca2+ signaling in cystic fibrosis
by: Fabrice eAntigny, et al.
Published: (2011-10-01)

Alteration of Membrane Cholesterol Content Plays a Key Role in Regulation of Cystic Fibrosis Transmembrane Conductance Regulator Channel Activity
by: Guiying Cui, et al.
Published: (2021-06-01)

Factors affecting efficacy of ciprofloxacin for treatment of pseudomonas pulmonary infections in cystic fibrosis
by: Ferguson, Marbeth I.
Published: (1990)

The role of ZC3H12A in «Pseudomonas aeruginosa» infection of airway epithelial cells and implication in Cystic Fibrosis
by: Zhou, Tianwei
Published: (2011)

Electrogenic ion transport in cultured human sweat gland epithelia : control and cystic fibrosis
by: Brayden, David James
Published: (1989)

Cystic Fibrosis–Related Diabetes: Pathophysiology and Therapeutic Challenges
by: Ryan Kelsey, et al.
Published: (2019-05-01)

Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis
by: Massimo Conese, et al.
Published: (2021-03-01)

Pathophysiology of age-dependent hypertension in male Sprague-Dawley rats
by: Hai, Jerry
Published: (2017)

The Physiology and Pathophysiology of a Fetal Splice Variant of the Cardiac Sodium Channel
by: Murphy, Lisa Lynn
Published: (2014)

Bacteriophages as a potential treatment for Pseudomonas aeruginosa mediated chest infections in cystic fibrosis patients
by: Hendon-Dunn, Charlotte
Published: (2011)

Emerging Therapeutic Approaches for Cystic Fibrosis
Published: (2020)

Tuberculosis, Anaemia and Erythropoietin: a study evaluating the role of erythropoietin in the pathophysiology of the anaemia of tuberculosis
by: Ebrahim, Osman
Published: (2021)

Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice
by: Barbara Dhooghe, et al.
Published: (2015-07-01)

Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
by: Antonio Recchiuti, et al.
Published: (2019-04-01)

Endothelin in cardiovascular physiology and pathophysiology
by: McMurdo, Lorraine
Published: (1993)

Studies on the pathophysiological basis of cystic fibrosis airway disease in newborn pigs
by: Hoegger, Mark Jeffrey
Published: (2015)

The pathogenesis and pathophysiology of low bone mineral density in adults with cystic fibrosis
by: Elkin, Sarah Louise
Published: (2005)

Freezing of gait in Parkinson’s disease: pathophysiology, risk factors and treatments
by: Chao Gao, et al.
Published: (2020-04-01)

Priapism: etiology, pathophysiology and management
by: Van Der Horst C., et al.
Published: (2003-01-01)

See into the future:understanding the acute and progressive pathophysiology of oxygen induced retinopathy for potential therapeutic development
by: Shao, Zhuo
Published: (2012)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
by: Schmidt BZ, et al.
Published: (2016-09-01)

Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis
by: Anita Balázs, et al.
Published: (2018-10-01)

Novel signaling mechanisms for Transforming Growth Factor-beta; activated kinase-1 (TAK1) in microtubule and endoplasmic reticulum dynamics
by: Shah, Nirav, Shah
Published: (2018)

Novel Therapeutic Targets and Emerging Treatments for Fibrosis
Published: (2018)

The Management of Patients With Idiopathic Pulmonary Fibrosis
by: Paolo Spagnolo, et al.
Published: (2018-07-01)

Cystic fibrosis transmembrane conductance regulator mutations at a referral center for cystic fibrosis
by: Cyntia Arivabeni de Araujo Correia Coutinho, et al.
Published: (2013-09-01)

Enhancing Cystic Fibrosis Immune Regulation
by: Anna M. van Heeckeren, et al.
Published: (2021-05-01)

Improved Growth Patterns in Cystic Fibrosis Mice after Loss of Histone Deacetylase 6
by: Sharon M. Rymut, et al.
Published: (2017-06-01)

Development of new treatments for cystic fibrosis
by: Chadwick, Sharon Lorna
Published: (1999)

Albendazole chemotherapy and antibody response in cystic and alveolar echinococcosis
by: Wen, Hao
Published: (1994)

Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis
by: Nico Derichs
Published: (2013-03-01)

Drugs and Targets in Fibrosis
by: Xiaoyi Li, et al.
Published: (2017-11-01)

Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes
by: Grace Y. Lam, et al.
Published: (2021-01-01)

An investigation into the role of selectins in the pathophysiology of sepsis and sepsis-induced acute lung injury
by: Ridings, Philip Charles
Published: (1996)

Tinnitus: Network pathophysiology-network pharmacology
by: Ana Belen eElgoyhen, et al.
Published: (2012-01-01)

Prostanoids, Diabetes and the Brain: unveiling a pathophysiological role for 15-deoxy-delta-12, 14-prostaglandin J2 in diabetes-related encephalopathy and cerebrovascular injury
by: Seshadri, Swathi
Published: (2008)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
by: Kiera H. Harwood, et al.
Published: (2021-07-01)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
by: Ryosuke Fukuda, et al.
Published: (2020-04-01)